CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 22,737	$ 36,375
Accounts receivable, net	31,000	50,729
Inventory, net	7,444	7,775
Prepaid expenses and other current assets	15,069	12,617
Income tax receivable	680	1,414
Total current assets	76,930	108,910
Property and equipment, net	1,013	1,103
Goodwill	30,600	30,600
Intangible assets, net	151,086	169,571
Other	235	257
Total assets	259,864	310,441
Current liabilities:
Accounts payable and accrued expenses	20,391	21,343
Accrued allowances	55,810	60,961
Interest payable	6,329	10,897
Treximet Secured Notes - current	0	11,103
Other liabilities - current	4,912	5,224
Total current liabilities	87,442	109,528
Convertible notes - long-term	105,217	104,071
Derivative liability	584	230
Contingent consideration	2,749	2,403
Treximet Secured Notes - long-term	172,677	172,250
Credit facilities - long-term	14,000	14,000
Arbitration award	17,410	17,522
Other liabilities - long-term	2,559	4,500
Total liabilities	402,638	424,504
Commitments and contingencies (notes 1, 3, 6, 7, 10 and 11)
STOCKHOLDERS' EQUITY
Preferred stock, $0.01 par value, authorized 10,000,000 shares; no shares issued and outstanding	0	0
Common stock, $.01 par value, 140,000,000 shares authorized, 10,015,641 shares issued and outstanding at March 31, 2017 and December 31, 2016	100	100
Additional paid-in capital	245,054	244,309
Accumulated other comprehensive loss	(73)	(79)
Accumulated deficit	(387,855)	(358,393)
Total stockholders' equity	(142,774)	(114,063)
Total liabilities and stockholders' equity	$ 259,864	$ 310,441